Evidence map›Paper›PMID 40351478›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2025

Gender difference in pre-clinical liver-directed gene therapy with lentiviral vectors.

Efrain Guzman, Cheen Khoo, Deirdre O'Connor, Gayathri Devarajan, Sharifah Iqball, Bernard Souberbielle, Kyriacos Mitrophanous, Yatish Lad

Abstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Efrain GuzmanOxford Biomedica (UK) Limited, Oxford, United Kingdom.
Cheen KhooOxford Biomedica (UK) Limited, Oxford, United Kingdom.
Deirdre O'ConnorOxford Biomedica (UK) Limited, Oxford, United Kingdom.
Gayathri DevarajanOxford Biomedica (UK) Limited, Oxford, United Kingdom.
Sharifah IqballOxford Biomedica (UK) Limited, Oxford, United Kingdom.
Bernard SouberbielleOxford Biomedica (UK) Limited, Oxford, United Kingdom.
Kyriacos MitrophanousOxford Biomedica (UK) Limited, Oxford, United Kingdom.
Yatish LadOxford Biomedica (UK) Limited, Oxford, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral vector-based therapies are effective therapeutics for the correction of several disorders, both in mouse models and in humans. Several pre-clinical studies have demonstrated differences in transduction efficiencies and therapeutic effect between male and female mice dosed with AAV-based gene therapy product candidates. Here, we report gender-specific transduction and transgene expression differences in mice dosed systemically with lentiviral vectors (LVV). Male mice systemically dosed with LVV carrying the reporter gene luciferase showed at least a 12-fold higher expression of luciferase and a higher vector copy number (VCN) in their livers compared with female mice. Lastly, PAH

Indexed as

Genetic TherapyGenetic VectorsLentivirusLiverAnimalsFemaleHumansLuciferasesMaleMiceMice, Inbred C57BLSex FactorsTransduction, GeneticTransgenesLuciferasesAAVadeno-associated virusgenderlentiviral vectorslivermurinePAH

Identifiers

PMID40351478
PMCPMC12061785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.